← Back to Search

Light Exposure and Sleep Scheduling for Teen Sleep Disorders

N/A

Waitlist Available

Led By Brant P Hasler, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Currently in 11th or 12th grade and enrolled in a traditional high-school; or cyber school with synchronous classes (not home-schooled)

Age 16-19 years

Must not have

Past or current bipolar disorder or psychotic disorder

Significant or unstable acute or chronic medical conditions

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during follow-ups after the manipulation through study completion, up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will study whether sleep disorders in adolescence are linked to an increased risk of substance abuse, and whether treatment can help.

Who is the study for?

This study is for teens aged 16-19, in their junior or senior year of high school (traditional or cyber but not home-schooled), who are physically and mentally healthy. Participants must have a late sleep schedule with weekend bedtimes at 1 AM or later, and can't be using drugs other than alcohol, cannabis, and nicotine.

What is being tested?

The trial tests if increasing morning light exposure, reducing evening blue light exposure, monitoring sleep patterns along with mood and substance use, and regulating sleep schedules can reduce the risk of substance abuse linked to delayed sleep phase in adolescents.

What are the potential side effects?

There may be minimal side effects from this behavioral intervention. However, changes in light exposure could potentially affect mood temporarily or disrupt usual sleeping patterns during the adjustment period.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a high school junior or senior in a traditional or online school with live classes.

Select...

I am between 16 and 19 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have or had bipolar or psychotic disorder.

Select...

I do not have any severe or unstable health conditions.

Select...

I have a sleep disorder that is not insomnia or delayed sleep phase disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during follow-ups after the manipulation through study completion, up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during follow-ups after the manipulation through study completion, up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and during follow-ups after the manipulation through study completion, up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Behavioral inhibition

Circadian alignment

Neural correlates of impulse control

+2 more

Secondary study objectives

Cannabis use

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ManipulationExperimental Treatment4 Interventions

For \~2 weeks, participants will be asked to adhere to the following: * Sleep scheduling--advance bedtime by 1.5 hours ( + sleep duration) * Decrease evening blue light exposure via blue blocker goggles (2 h before bed) * Increase morning bright light exposure via bright light goggles (30 m after rise) * Monitor sleep, mood, and substance use via smartphone-based platform and wrist actigraph

Group II: ControlActive Control1 Intervention

For \~2 weeks, participants will asked to adhere to the following: - Monitor sleep, mood, and substance use via smartphone-based platform and wrist actigraph

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Sleep scheduling

2009

Completed Phase 2

~70

0 / 5Eligibility criteria met